Home / Inspections / 1102871

FDA Inspection 1102871 — Naveed Razzaque, MD

Naveed Razzaque, MD — FEI 3015651362

The FDA completed an inspection of Naveed Razzaque, MD on Sep 25, 2019 in Bridgeton, MO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgeton, MO (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.